News
2 Growth Stocks to Buy Hand Over Fist in April
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.
2 Growth Stocks to Buy Hand Over Fist in April
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.
UnitedHealth's 6.4% Drop Brings Microsoft This Much Closer to Becoming the Most Important Stock in the Dow Jones Industrial Average
Microsoft (NASDAQ: MSFT) is currently the only company worth over $3 trillion. That makes it the most heavily weighted stock in both the S&P 500 and the Nasdaq Composite, but not the Dow Jones
UnitedHealth's 6.4% Drop Brings Microsoft This Much Closer to Becoming the Most Important Stock in the Dow Jones Industrial Average
Microsoft (NASDAQ: MSFT) is currently the only company worth over $3 trillion. That makes it the most heavily weighted stock in both the S&P 500 and the Nasdaq Composite, but not the Dow Jones
Is Zscaler a Buy on the Dip?
Cybersecurity has been one of the hottest investment sectors in recent years. Given the number of high-profile cybersecurity attacks and breaches, this probably should not be surprising. For
Is Zscaler a Buy on the Dip?
Cybersecurity has been one of the hottest investment sectors in recent years. Given the number of high-profile cybersecurity attacks and breaches, this probably should not be surprising. For
Got $1,000? 2 Bulletproof Stocks to Buy in 2024 and Hold for the Long Haul
While no one can say with absolute certainty what the market will or won't do in 2024, finding great stocks that have the power to stand the test of time in your portfolio doesn't have to be
Got $1,000? 2 Bulletproof Stocks to Buy in 2024 and Hold for the Long Haul
While no one can say with absolute certainty what the market will or won't do in 2024, finding great stocks that have the power to stand the test of time in your portfolio doesn't have to be
Why Humana Stock Fell 10.9% This Week
Shares of Humana (NYSE: HUM) are down 11.8% so far this week as of Thursday's close, according to data provided by S&P Global Market Intelligence, after the U.S. Centers for Medicare and Medicaid
Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Stephanie Eken as the Company’s new chief medical officer. Dr. Eken is a psychiatrist with more than two
QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho" or the “Company”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its QuickVue COVID-19 test. This clearance allows
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to
EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
Should You Buy This Blue Chip Stock's Dip Hand Over Fist?
Cyberattacks can disrupt corporations, and you've seen that play out in recent weeks. UnitedHealth Group (NYSE: UNH) fell roughly $14 billion behind in paying claims after a hacker group attacked
Should You Buy This Blue Chip Stock's Dip Hand Over Fist?
Cyberattacks can disrupt corporations, and you've seen that play out in recent weeks. UnitedHealth Group (NYSE: UNH) fell roughly $14 billion behind in paying claims after a hacker group attacked
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
If you're an everyday investor looking for stocks that can deliver steadily rising dividend payouts over long periods, the healthcare sector is the right place to begin your search. People get sick
This Beleaguered Ultra-High-Yield Dividend Stock Might Soon Get Some Much-Needed Relief
Medical Properties Trust (NYSE: MPW) has fallen on hard times over the past few years. Shares of the hospital-focused real estate investment trust (REIT) have lost more than 80% of their value from
This Beleaguered Ultra-High-Yield Dividend Stock Might Soon Get Some Much-Needed Relief
Medical Properties Trust (NYSE: MPW) has fallen on hard times over the past few years. Shares of the hospital-focused real estate investment trust (REIT) have lost more than 80% of their value from
EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
Why Medical Properties Trust Stock Popped Today
Shares of Medical Properties Trust (NYSE: MPW) soared 18.6% on Wednesday after the largest tenant of the healthcare facilities-focused real estate investment trust (REIT) announced a deal to sell
Why Medical Properties Trust Stock Popped Today
Shares of Medical Properties Trust (NYSE: MPW) soared 18.6% on Wednesday after the largest tenant of the healthcare facilities-focused real estate investment trust (REIT) announced a deal to sell
Tufts Medicine and Acadia Healthcare Break Ground on New Behavioral Health Hospital to Serve the Greater Boston Area
Tufts Medicine, a leading Massachusetts integrated, academic health system, and Acadia Healthcare Company, the largest standalone provider of behavioral health services in the U.S., today held a
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P